These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 26335919)
1. Evaluation and Management of Proteinuria After Kidney Transplantation. Tsampalieros A; Knoll GA Transplantation; 2015 Oct; 99(10):2049-60. PubMed ID: 26335919 [TBL] [Abstract][Full Text] [Related]
2. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management. Knoll GA Am J Kidney Dis; 2009 Dec; 54(6):1131-44. PubMed ID: 19726115 [TBL] [Abstract][Full Text] [Related]
3. Posttransplantation proteinuria: an approach to diagnosis and management. Shamseddin MK; Knoll GA Clin J Am Soc Nephrol; 2011 Jul; 6(7):1786-93. PubMed ID: 21734095 [TBL] [Abstract][Full Text] [Related]
4. Management of proteinuria in clinical practice after kidney transplantation. Ruiz JC; Sánchez-Fructuoso A; Zárraga S Transplant Rev (Orlando); 2012 Jan; 26(1):36-43. PubMed ID: 22137731 [TBL] [Abstract][Full Text] [Related]
5. Early proteinuria after renal transplantation and allograft outcomes. Gulleroglu K; Baskin E; Bayrakci U; Akdur A; Moray G; Haberal M Transplant Proc; 2014; 46(1):141-4. PubMed ID: 24507040 [TBL] [Abstract][Full Text] [Related]
6. Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists. Marx C; Busch M; Ott U; Gerth J; Wolf G Clin Transplant; 2010; 24(5):626-30. PubMed ID: 19925471 [TBL] [Abstract][Full Text] [Related]
7. Low-grade proteinuria and microalbuminuria in renal transplantation. Halimi JM Transplantation; 2013 Jul; 96(2):121-30. PubMed ID: 23435457 [TBL] [Abstract][Full Text] [Related]
8. Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial. Oblak M; Mlinšek G; Kandus A; Buturović-Ponikvar J; Arnol M Transpl Int; 2018 Dec; 31(12):1391-1404. PubMed ID: 30062716 [TBL] [Abstract][Full Text] [Related]
10. Management of proteinuria in the transplanted patient. Seeman T Pediatr Nephrol; 2015 Jun; 30(6):889-903. PubMed ID: 25159718 [TBL] [Abstract][Full Text] [Related]
11. Early inhibition of the renin-angiotensin system improves the long-term graft survival of single pediatric donor kidneys transplanted in adult recipients. Zhang R; Laguardia H; Paramesh A; Mills K; Killackey M; McGee J; Alper B; Simon E; Lee Hamm L; Slakey D Transpl Int; 2013 Jun; 26(6):601-7. PubMed ID: 23506676 [TBL] [Abstract][Full Text] [Related]
12. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy. Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers. Opelz G; Döhler B Transplantation; 2014 Feb; 97(3):310-5. PubMed ID: 24492421 [TBL] [Abstract][Full Text] [Related]
15. Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months. González Monte E; Andrés A; Polanco N; Toribio MJ; Santana R; Gutiérrez Martínez E; González J; Ramírez E; Hernández A; Morales E; Praga M; Morales JM Transplant Proc; 2010 Oct; 42(8):2899-901. PubMed ID: 20970564 [TBL] [Abstract][Full Text] [Related]
16. Significance and management of proteinuria in kidney transplant recipients. Amer H; Cosio FG J Am Soc Nephrol; 2009 Dec; 20(12):2490-2. PubMed ID: 19820126 [TBL] [Abstract][Full Text] [Related]
17. New options and perspectives for proteinuria management after kidney transplantation. Soler MJ; Riera M; Gutierrez A; Pascual J Transplant Rev (Orlando); 2012 Jan; 26(1):44-52. PubMed ID: 22137732 [TBL] [Abstract][Full Text] [Related]
18. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L; Kocks MJ; Laverman GD; Navis G Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [TBL] [Abstract][Full Text] [Related]
19. Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Renke M; Tylicki L; Rutkowski P; Knap N; Zietkiewicz M; Neuwelt A; Aleksandrowicz E; Łysiak-Szydłowska W; Woźniak M; Rutkowski B Acta Biochim Pol; 2010; 57(1):119-23. PubMed ID: 20309434 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive therapy in the presence of proteinuria. Sarafidis PA; Khosla N; Bakris GL Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]